167 related articles for article (PubMed ID: 33112830)
1. Denosumab for management of severe hypercalcemia in primary hyperparathyroidism.
Eremkina A; Krupinova J; Dobreva E; Gorbacheva A; Bibik E; Samsonova M; Ajnetdinova A; Mokrysheva N
Endocr Connect; 2020 Oct; 9(10):1019-1027. PubMed ID: 33112830
[TBL] [Abstract][Full Text] [Related]
2. Successful Use of Denosumab for Life-Threatening Hypercalcemia in a Pediatric Patient with Primary Hyperparathyroidism.
Mamedova E; Kolodkina A; Vasilyev EV; Petrov V; Belaya Z; Tiulpakov A
Horm Res Paediatr; 2020; 93(4):272-278. PubMed ID: 32998142
[TBL] [Abstract][Full Text] [Related]
3. Denosumab can be used successfully as a bridge to surgery in patients with severe hypercalcemia due to primary hyperparathyroidism.
Kuchay MS; Mathew A; Kaur P; Mishra SK
Arch Endocrinol Metab; 2021 Oct; 65(5):669-673. PubMed ID: 34591412
[TBL] [Abstract][Full Text] [Related]
4. Denosumab treatment for refractory hypercalcemia in a hemodialysis patient with tertiary hyperparathyroidism.
Zhang P; Yu Y; Gao Y; Yuan G; Zhang J; Wang W
Hemodial Int; 2023 Apr; 27(2):E23-E28. PubMed ID: 36719850
[TBL] [Abstract][Full Text] [Related]
5. Palliative treatment of uncontrollable hypercalcemia due to parathyrotoxicosis: denosumab as rescue therapy.
Jumpertz von Schwartzenberg R; Elbelt U; Ventz M; Mai K; Kienitz T; Maurer L; Rose T; Rückert JC; Strasburger CJ; Spranger J
Endocrinol Diabetes Metab Case Rep; 2015; 2015():150082. PubMed ID: 26605043
[TBL] [Abstract][Full Text] [Related]
6. Utility of denosumab therapy in management of severe hypercalcaemia caused by primary hyperparathyroidism - Case report with review of literature.
Jadhao P; Mangaraj S
J R Coll Physicians Edinb; 2023 Jun; 53(2):104-108. PubMed ID: 36825782
[TBL] [Abstract][Full Text] [Related]
7. Hypercalcemia upon denosumab withdrawal in primary hyperparathyroidism: a case report and literature review.
Camponovo C; Aubry-Rozier B; Lamy O; Gonzalez Rodriguez E
Osteoporos Int; 2020 Dec; 31(12):2485-2491. PubMed ID: 33057735
[TBL] [Abstract][Full Text] [Related]
8. Preoperative normal level of parathyroid hormone signifies an early and mild form of primary hyperparathyroidism.
Bergenfelz A; Lindblom P; Lindergård B; Valdemarsson S; Westerdahl J
World J Surg; 2003 Apr; 27(4):481-5. PubMed ID: 12658497
[TBL] [Abstract][Full Text] [Related]
9. Denosumab for the Treatment of Hypercalcemia in a Patient With Parathyroid Carcinoma: A Case Report.
Roukain A; Alwan H; Bongiovanni M; Sykiotis GP; Kopp PA
Front Endocrinol (Lausanne); 2021; 12():794988. PubMed ID: 35173680
[TBL] [Abstract][Full Text] [Related]
10. Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism.
Beysel S; Caliskan M; Kizilgul M; Apaydin M; Kan S; Ozbek M; Cakal E
BMC Cardiovasc Disord; 2019 May; 19(1):106. PubMed ID: 31068134
[TBL] [Abstract][Full Text] [Related]
11. Primary hyperparathyroidism presenting as hypercalcemic crisis: Twenty-year experience.
Singh DN; Gupta SK; Kumari N; Krishnani N; Chand G; Mishra A; Agarwal G; Verma AK; Mishra SK; Agarwal A
Indian J Endocrinol Metab; 2015; 19(1):100-5. PubMed ID: 25593835
[TBL] [Abstract][Full Text] [Related]
12. Intraoperative Parathyroid Hormone Monitoring in Parathyroidectomy for Tertiary Hyperparathyroidism.
Ermer JP; Kelz RR; Fraker DL; Wachtel H
J Surg Res; 2019 Dec; 244():77-83. PubMed ID: 31279997
[TBL] [Abstract][Full Text] [Related]
13. [The efficacy and safety of intravenous bisphosphonates in the treatment of primary hyperparathyroidism complicated by hypercalcemia crisis].
Han GY; Wang O; Xing XP; Meng XW; Lian XL; Guan H; Ye W; Xia WB; Li M; Jiang Y; Hu YY; Liu HC; Cui QC
Zhonghua Nei Ke Za Zhi; 2009 Sep; 48(9):729-33. PubMed ID: 20079207
[TBL] [Abstract][Full Text] [Related]
14. Daily follow-up of serum parathyroid hormone and calcium after surgery for primary hyperparathyroidism.
Debruyne F; Delaere P; Ostyn F; Van den Bruel A; Bouillon R
J Otolaryngol; 1999 Dec; 28(6):305-8. PubMed ID: 10604157
[TBL] [Abstract][Full Text] [Related]
15. [Hypercalcemic crisis and hypocalcemic tetany].
Kasperk C
Internist (Berl); 2017 Oct; 58(10):1029-1036. PubMed ID: 28835974
[TBL] [Abstract][Full Text] [Related]
16. [Normocalcemic primary hyperparathyroidism].
Spivacow FR; Sapag Durán A; Zanchetta MB
Medicina (B Aires); 2014; 74(6):457-61. PubMed ID: 25555006
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Persistent Hypercalcemia and Hyperparathyroidism With Cinacalcet After Successful Kidney Transplantation.
Ważna-Jabłońska E; Gałązka Z; Durlik M
Transplant Proc; 2016 Jun; 48(5):1623-5. PubMed ID: 27496458
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid Crisis: A Case of Elective Parathyroidectomy.
Adeniran U; Ji B; Hussein I; Soni L
Cureus; 2023 Jun; 15(6):e40251. PubMed ID: 37440804
[TBL] [Abstract][Full Text] [Related]
19. Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. Groupe d'Etude des Tumeurs á Calcitonine (GETC, French Calcitonin Tumors Study Group), French Association of Endocrine Surgeons.
Kraimps JL; Denizot A; Carnaille B; Henry JF; Proye C; Bacourt F; Sarfati E; Dupond JL; Maes B; Travagli JP; Boneu A; Roger P; Houdent C; Barbier J; Modigliani E
World J Surg; 1996 Sep; 20(7):808-12; discussion 812-3. PubMed ID: 8678955
[TBL] [Abstract][Full Text] [Related]
20. Assessing the risk of hypercalcemic crisis in patients with primary hyperparathyroidism.
Lowell AJ; Bushman NM; Wang X; Ma Y; Pitt SC; Sippel RS; Schneider DF; Randle RW
J Surg Res; 2017 Sep; 217():252-257. PubMed ID: 28711370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
